Antithymocyte globulin improves the survival of patients with myelodysplastic syndrome undergoing HLA-matched unrelated donor and haplo-identical donor transplants. - Wikidata - wikimedia - TriplyDB

Antithymocyte globulin improves the survival of patients with myelodysplastic syndrome undergoing HLA-matched unrelated donor and haplo-identical donor transplants.

Antithymocyte globulin improves the survival of patients with myelodysplastic syndrome undergoing HLA-matched unrelated donor and haplo-identical donor transplants.

http://www.wikidata.org/entity/Q37681792

about

Antithymocyte globulin improves the survival of patients with myelodysplastic syndrome undergoing HLA-matched unrelated donor and haplo-identical donor transplants.

http://www.wikidata.org/entity/Q37681792

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antithymocyte globulin improve ...... o-identical donor transplants.

@en

Antithymocyte globulin improve ...... o-identical donor transplants.

@nl

type

label

Antithymocyte globulin improve ...... o-identical donor transplants.

@en

Antithymocyte globulin improve ...... o-identical donor transplants.

@nl

prefLabel

Antithymocyte globulin improve ...... o-identical donor transplants.

@en

Antithymocyte globulin improve ...... o-identical donor transplants.

@nl

P1433

Q37681792-628D5DF5-6940-4A0A-B7EA-4BABC4F0FF3F

P1476

Q37681792-CCF1C738-B52A-4B75-9613-AAD9A7E7DE27

P2093

Q37681792-0D26810C-9B66-48CB-953B-C153CD4378D1

Q37681792-2210FE38-854D-4DB5-AC77-70D0F983E278

Q37681792-37ABECE9-D8F4-4DF3-A1DA-8913822C2558

Q37681792-543C7E66-FA03-4FD7-8732-A5303FB9FDC1

Q37681792-8E2037A0-1303-4DFF-9FF8-62FC58CB3BC7

Q37681792-8F65BD58-76AC-496A-BB6E-CCC73753453E

Q37681792-9BAD9B02-51F7-4CE0-9657-835FC7887007

Q37681792-9FA7E038-7CC3-4C39-9C2F-E526651D8257

Q37681792-A4A416B7-3259-41DB-8268-3C079EE167B8

Q37681792-CD715CDF-5626-4313-9A4E-EA79566B320D

P2860

Q37681792-0B8F8AFE-7451-4D88-A7C5-A3102F219247

Q37681792-0E69A099-AB00-48F1-85D6-731711AF3567

Q37681792-12310EE2-F45F-4571-BDF0-CC2FCDA47435

Q37681792-2243E315-DFBF-4E35-BA58-92475B102919

Q37681792-31498240-0FBB-4F45-839E-386146CC11EE

Q37681792-3DAF17FC-D151-4D91-B8A7-7990086D212C

Q37681792-485374A2-8052-4500-AD28-3092CA7E984A

Q37681792-586FB950-14A4-42BA-BC73-0F9FECC30B78

Q37681792-67B6D1B2-C973-4FD8-8512-0FAFC379F3C9

Q37681792-695E535D-905E-48A1-BFF0-DA90507FA327

P2888

Q37681792-D4C5F801-DEA2-49FE-9F34-46341016E357

P304

Q37681792-63546E1E-989D-412A-872C-A014A228DD54

P31

Q37681792-2F5DCD62-0086-42E0-A6B7-BB8451B70EE7

P356

Q37681792-292CD46E-CA96-43B0-BDB8-5BB9582F4D0D

P407

Q37681792-DCA1A319-E8DC-4A91-8780-E00DA8EA5931

P478

Q37681792-7EA9294B-5167-4A93-9E7D-2F819B4E08DA

P577

Q37681792-F53AF6B5-E23C-4ABE-8698-3BCC0B2617B0

P698

Q37681792-46C76BDF-4AEC-4E14-836D-677AFC8B9B5C

P932

Q37681792-09E3A1F6-0AFB-4895-8350-986B966DB2E9

P356

P1433

Scientific Reports

P1476

Antithymocyte globulin improve ...... o-identical donor transplants.

@en

P2093

De-Pei Wu

http://www.w3.org/2001/XMLSchema#string

Hong Liu

http://www.w3.org/2001/XMLSchema#string

Hong Wang

http://www.w3.org/2001/XMLSchema#string

Jin-Yi Zhou

http://www.w3.org/2001/XMLSchema#string

Miao Miao

http://www.w3.org/2001/XMLSchema#string

Song Jin

http://www.w3.org/2001/XMLSchema#string

Su-Ning Chen

http://www.w3.org/2001/XMLSchema#string

Tong-Tong Zhang

http://www.w3.org/2001/XMLSchema#string

Wei-Yang Li

http://www.w3.org/2001/XMLSchema#string

Xiang Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

Early CMV viremia is associated with impaired viral control following nonmyeloablative hematopoietic cell transplantation with a total lymphoid irradiation and antithymocyte globulin preparative regimen.

Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors.

Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation.

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.

Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin

Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation.

P2888

P304

43488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP43488

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28262717

http://www.w3.org/2001/XMLSchema#string

P932

5337979

http://www.w3.org/2001/XMLSchema#string